Maurizi N, Rella V, Fumagalli C, Salerno S, Castelletti S, Dagradi F et al (2020) Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy. Int J Cardiol 300:191–5

Article  PubMed  Google Scholar 

Emdin M, Aimo A, Rapezzi C, Fontana M, Perfetto F, Seferović PM et al (2019) Treatment of cardiac transthyretin amyloidosis: an update. Eur Heart J 40(45):3699–706

Article  CAS  PubMed  Google Scholar 

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404–12

Article  CAS  PubMed  Google Scholar 

Fontana M, Chung R, Hawkins PN, Moon JC (2015) Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev 20(2):133–44

CAS  PubMed  Google Scholar 

Quarta CC, Fontana M, Damy T, Catini J, Simoneau D, Mercuri M et al (2022) Changing paradigm in the treatment of amyloidosis: from disease-modifying drugs to anti-fibril therapy. Front Cardiovasc Med 9:1073503

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rapezzi C, Aimo A, Barison A, Emdin M, Porcari A, Linhart A et al (2022) Restrictive cardiomyopathy: definition and diagnosis. Eur Heart J 43(45):4679–93

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coffey S, Cox B, Williams MJ (2014) The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol 63(25 Pt A):2852–2861

Article  PubMed  Google Scholar 

Peskó G, Jenei Z, Varga G, Apor A, Vágó H, Czibor S et al (2019) Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance. Cardiovasc Ultrasound 17(1):32

PubMed  PubMed Central  Google Scholar 

Castaño A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A et al (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38(38):2879–87

Article  PubMed  PubMed Central  Google Scholar 

Scully PR, Treibel TA, Fontana M, Lloyd G, Mullen M, Pugliese F et al (2018) Prevalence of cardiac amyloidosis in patients referred for transcatheter aortic valve replacement. J Am Coll Cardiol 71(4):463–4

Article  PubMed  PubMed Central  Google Scholar 

Treibel TA, Fontana M, Gilbertson JA, Castelletti S, White SK, Scully PR et al (2016) Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc imaging 9(8):e005066. https://doi.org/10.1161/CIRCIMAGING.116.005066. PMID: 27511979.

Longhi S, Lorenzini M, Gagliardi C, Milandri A, Marzocchi A, Marrozzini C et al (2016) Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging 9(3):325–7

Article  PubMed  Google Scholar 

Singal AK, Bansal R, Singh A, Dorbala S, Sharma G, Gupta K et al (2021) Concomitant transthyretin amyloidosis and severe aortic stenosis in elderly Indian population: a pilot study. JACC CardioOncology. 3(4):565–76

Article  PubMed  PubMed Central  Google Scholar 

Ternacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A et al (2019) Aortic stenosis and cardiac amyloidosis: JACC review topic of the week. J Am Coll Cardiol 74(21):2638–51

PubMed  Google Scholar 

Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G et al (2022) Redefining the epidemiology of cardiac amyloidosis a systematic review and meta-analysis of screening studies. Eur Heart J Fail 24(12):2342–2351

Article  CAS  Google Scholar 

Nitsche C, Aschauer S, Kammerlander AA, Schneider M, Poschner T, Duca F et al (2020) Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. Eur J Heart Fail 22(10):1852–62

Article  CAS  PubMed  Google Scholar 

Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C et al (2021) Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol 77(2):128–39

CAS  PubMed  PubMed Central  Google Scholar 

Marcoux J, Mangione PP, Porcari R, Degiacomi MT, Verona G, Taylor GW et al (2015) A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis. EMBO Mol Med 7(10):1337–49

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cantarutti C, Mimmi MC, Verona G, Mandaliti W, Taylor GW, Mangione PP et al (2022) Calcium binds to transthyretin with low affinity. Biomolecules 12(8):1066. https://doi.org/10.3390/biom12081066. PMID: 36008960; PMCID: PMC9406000.

Sud K, Narula N, Aikawa E, Arbustini E, Pibarot P, Merlini G et al (2023) The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis. Nat Rev Cardiol 20(6):418–428. https://doi.org/10.1038/s41569-022-00818-2. Epub 2023 Jan 9. Erratum in: Nat Rev Cardiol. 2023 Feb 17;: PMID: 36624274; PMCID: PMC10199673.

Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M et al (2019) Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail 12(9):e006075

Article  PubMed  PubMed Central  Google Scholar 

Merlini G, Dispenzieri A, Sanchorawala V, Schönland SO, Palladini G, Hawkins PN et al (2018) Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4(1):38

Article  PubMed  Google Scholar 

Vergaro G, Castiglione V, Aimo A, Prontera C, Masotti S, Musetti V et al (2023) N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis. Eur J Heart Fail 25(3):335–46

Article  CAS  PubMed  Google Scholar 

Tang CX, Petersen SE, Sanghvi MM, Lu GM, Zhang LJ (2019) Cardiovascular magnetic resonance imaging for amyloidosis: the state-of-the-art. Trends Cardiovasc Med 29(2):83–94

Article  CAS  PubMed  Google Scholar 

Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A et al (2021) Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail 23(4):512–526

Article  PubMed  Google Scholar 

Oike F, Usuku H, Yamamoto E, Marume K, Takashio S, Ishii M et al (2022) Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis. ESC Heart Fail 9(3):1976–86

Article  PubMed  PubMed Central  Google Scholar 

Robin G, Cognet T, Bouisset F, Cariou E, Méjean S, Pradel S et al (2021) Value of longitudinal strain to identify wild-type transthyretin amyloidosis in patients with aortic stenosis. Circulation journal : Official journal of the Japanese Circulation Society 85(9):1494–504

Article  CAS  PubMed  Google Scholar 

Cersosimo A, Bonelli A, Lombardi CM, Moreo A, Pagnesi M, Tomasoni D et al (2023) Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis. Front Cardiovasc Med 10:1108696

Article  PubMed  PubMed Central  Google Scholar 

Scully PR, Bastarrika G, Moon JC, Treibel TA (2018) Myocardial extracellular volume quantification by cardiovascular magnetic resonance and computed tomography. Curr Cardiol Rep 20(3):15

Article  PubMed  PubMed Central  Google Scholar 

Frangogiannis NG (2017) The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Investig 127(5):1600–12

PubMed  PubMed Central  Google Scholar 

Scully PR, Patel KP, Saberwal B, Klotz E, Augusto JB, Thornton GD et al (2020) Identifying cardiac amyloid in aortic stenosis: ECV quantification by CT in TAVR patients. JACC Cardiovasc Imaging 13(10):2177–89

Article  PubMed  PubMed Central  Google Scholar 

Tavoosi A, Brito JBO, El Mais H, Small TD, Crean AM, Chow BJW et al (2023) Dual versus single energy cardiac CT to measure extra cellular volume in cardiac amyloidosis: correlations with cardiac MRI. IJC Heart Vasc 44

Gama F, Rosmini S, Bandula S, Patel KP, Massa P, Tobon-Gomez C et al (2022) Extracellular volume fraction by computed tomography predicts long-term prognosis among patients with cardiac amyloidosis. JACC Cardiovasc Imaging 15(12):2082–94

Article  PubMed  Google Scholar 

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43(7):561–632

Article  PubMed  Google Scholar 

Hussain M, Hanna M, Griffin BP, Conic J, Patel J, Fava AM, Watson C, Phelan DM, Jellis C, Grimm RA, Rodriguez LL, Schoenhagen P, Hachamovitch R, Jaber WA, Cremer PC, Collier P (2020) Aortic valve calcium in patients with transthyretin cardiac amyloidosis: a propensity-matched analysis. Circ Cardiovasc Imaging 13(10):e011433. https://doi.org/10.1161/CIRCIMAGING.120.011433. Epub 2020 Sep 23. PMID: 32967445.

Hussain M, Hanna M, Rodriguez L, Griffin B, Watson C, Phelan D et al (2020) Subthreshold aortic valve calcium scores in severe aortic stenosis and transthyretin cardiac amyloidosis. JACC Case Rep 2(14):2205–9

Article  PubMed  PubMed Central  Google Scholar 

Ternacle J, Pibarot P, Clavel MA (2020) Aortic stenosis and cardiac amyloidosis: watch out for traps! JACC Case Rep 2(14):2210–2

Article  PubMed  PubMed Central  Google Scholar 

Ho JS, Kor Q, Kong WK, Lim YC, Chan MY, Syn NL et al (2022) Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: a systematic review and meta-analysis. Hellenic J Cardiol: HJC = Hellenike Kardiologike Epitheorese 64:67–76

Article  PubMed  Google Scholar 

Ricci F, Ceriello L, Khanji MY, Dangas G, Bucciarelli-Ducci C, Di Mauro M et al (2021) Prognostic significance of cardiac amyloidosis in patients with aortic stenosis: a systematic review and meta-analysis. JACC Cardiovasc Imaging 14(1):293–5

Article  PubMed  Google Scholar 

Myasoedova VA, Conte M, Valerio V, Moschetta D, Massaiu I, Petraglia L et al (2022) Red flags, prognostic impact, and management of patients with cardiac amyloidosis and aortic valve stenosis: a systematic review and meta-analysis. Front Med 9:858281

Article